Cencora, Inc.
COR Healthcare Medical Distribution
Cencora, Inc.’s revenue for fiscal 2026 (year ended September 2026) was $337.4 billion, up 5.00% from fiscal 2025.
- Revenue
- +5.52%
- EPS
- +258.4%
- Free cash flow
- −7.81%
- Total debt
- +47.1%
Quarter to September 2026, against a year earlier
Follow COR
Alert me
Cencora, Inc. (COR) Total debt
Cencora, Inc.'s total debt at the end of fiscal 2026 was $11.3B, up 47.1% from $7.7B in fiscal 2025. Over the past ten years it has ranged from $3.7B (fiscal 2015) to $11.3B (fiscal 2026) — the current reading is the highest in ten years. Cencora, Inc. ranks 2nd of 12 Medical Distribution companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2026 | $11.3B | 47.06% |
| FY2025 | $7.7B | 74.58% |
| FY2024 | $4.4B | (8.34%) |
| FY2023 | $4.8B | (16.05%) |
| FY2022 | $5.7B | (14.68%) |
| FY2021 | $6.7B | 62.25% |
| FY2020 | $4.1B | (8.32%) |
| FY2019 | $4.5B | (3.63%) |
| FY2018 | $4.7B | 22.90% |
| FY2017 | $3.8B | (14.99%) |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $11.3B | (3.90%) |
| Jun 2026 | $11.7B | (5.35%) |
| Mar 2026 | $12.4B | 56.35% |
| Dec 2025 | $7.9B | 3.41% |
| 43 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| MCK McKesson Corporation compare | $13.8B |
| COR Cencora, Inc. | $11.3B |
| CAH Cardinal Health, Inc. compare | $8.8B |
| HSIC Henry Schein, Inc. compare | $2.5B |
| ACH Accendra Health, Inc. compare | $1.7B |
| FOCL FocalTherics compare | $40.1M |
| YI 111, Inc. Sponsored ADR compare | $37.3M |
| COSM Cosmos Health Inc. compare | $11.8M |
| AHG Akso Health Group Sponsored ADR compare | $4.6M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on COR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement